Skip to Main Content

Author Details

Mary Eileen Dolan
University of Chicago
1981
289
69
PMIDPaper TitleJournal TitlePublished Year
37966940Impact of pain and adverse health outcomes on long-term US testicular cancer survivors.J Natl Cancer Inst2024
36097363Comprehensive association analysis of speech recognition thresholds after cisplatin-based chemotherapy in survivors of adult-onset cancer.Cancer Med2023
36626694Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy.J Clin Oncol2023
36637632Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy.J Cancer Surviv2023
36866529The Gene Ontology knowledgebase in 2023.Genetics2023
35322580Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy.Cancer Med2022
36571071Chicago EYES on Cancer: Fostering Diversity in Biomedicine through Cancer Research Training for Students and Teachers.J STEM Outreach2022
35067571Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments.Ear Hear2022
34286861Clinical and genetic risk factors for radiation-associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort.Cancer2021
35694367Adapting Pathway Programs to the Virtual World: Insights from the Chicago EYES on Cancer Response to COVID-19-Related Disruptions to Training.J STEM Outreach2021
33575800Genetically regulated expression underlies cellular sensitivity to chemotherapy in diverse populations.Hum Mol Genet2021
33742760Identification of small molecules that mitigate vincristine-induced neurotoxicity while sensitizing leukemia cells to vincristine.Clin Transl Sci2021
34793465Genomic diversity of bacteriophages infecting Rhodobacter capsulatus and their relatedness to its gene transfer agent RcGTA.PLoS One2021
32122921Genomic Variants of Cytarabine Sensitivity Associated with Treatment-Related Mortality in Pediatric AML: A Report from the Children's Oncology Group.Clin Cancer Res2020
32998964Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors.Clin Cancer Res2020
29795408Integration of genetic and functional genomics data to uncover chemotherapeutic induced cytotoxicity.Pharmacogenomics J2019
31779641RegSNPs-intron: a computational framework for predicting pathogenic impact of intronic single nucleotide variants.Genome Biol2019
31296530Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy.Clin Cancer Res2019
30305294Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities.Clin Cancer Res2019
29181717Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results.Breast Cancer Res Treat2018
30236383Peripheral neuropathy in children and adolescents treated for cancer.Lancet Child Adolesc Health2018
30231410Role of Germline Genetics in Identifying Survivors at Risk for Adverse Effects of Cancer Treatment.Am Soc Clin Oncol Educ Book2018
29335598Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung Adenocarcinoma.Sci Rep2018
28039263Variants in <i>WFS1</i> and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.Clin Cancer Res2017
28335481Genetic Variants Contributing to Colistin Cytotoxicity: Identification of TGIF1 and HOXD10 Using a Population Genomics Approach.Int J Mol Sci2017
28442506Genome-Wide Association Studies of Chemotherapeutic Toxicities: Genomics of Inequality.Clin Cancer Res2017
28645005Application of stem cell derived neuronal cells to evaluate neurotoxic chemotherapy.Stem Cell Res2017
28902521Identification of Novel Protein Expression Changes Following Cisplatin Treatment and Application to Combination Therapy.J Proteome Res2017
28611204Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.Clin Cancer Res2017
26774046Evaluation of inter-batch differences in stem-cell derived neurons.Stem Cell Res2016
26556766Chemotherapy-induced peripheral neuropathy: Current status and progress.Gynecol Oncol2016
27354478Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.J Clin Oncol2016
27143689Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.Clin Cancer Res2016
25818895SCAN database: facilitating integrative analyses of cytosine modification and expression QTL.Database (Oxford)2015
26178744Characterization of CpG sites that escape methylation on the inactive human X-chromosome.Epigenetics2015
26015512Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy.Clin Cancer Res2015
25934575Hydroxylation and N-dechloroethylation of Ifosfamide and deuterated Ifosfamide by the human cytochrome p450s and their commonly occurring polymorphisms.Drug Metab Dispos2015
25710658Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.JAMA2015
25689802Modeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cells.PLoS One2015
24699359Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapy.PLoS Genet2014
25119182Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children's Oncology Group.Cancer Chemother Pharmacol2014
25087611Identification and validation of genetic variants that influence transcription factor and cell signaling protein levels.Am J Hum Genet2014
24799323Poly-omic prediction of complex traits: OmicKriging.Genet Epidemiol2014
24943591Linking the genetic architecture of cytosine modifications with human complex traits.Hum Mol Genet2014
24549002Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients.Clin Pharmacol Ther2014
24568970The role of gene body cytosine modifications in MGMT expression and sensitivity to temozolomide.Mol Cancer Ther2014
24595012Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analyses.Pharmacogenet Genomics2014
24623533Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics.J Natl Cancer Inst2014
21844884Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.Pharmacogenomics J2013
24367505EPS8 inhibition increases cisplatin sensitivity in lung cancer cells.PLoS One2013
  • 1 - 50 of 289

Recommended Authors

Jianfeng Li
Mitchell Cancer Institute, University of South Alabama
Career Start Year 2008
Number of shared co-authors 0
Min Shen
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 2003
Number of shared co-authors 2
Zhuo Chen
The First Hospital of Lanzhou University
Career Start Year 2002
Number of shared co-authors 0
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 4
Mahadev Rao
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
Career Start Year 1998
Number of shared co-authors 1
Ann-Sofie Jemth
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 0
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Qingyi Wei
South China University of Technology
Career Start Year 1992
Number of shared co-authors 2
James M Ford
Stanford University
Career Start Year 1989
Number of shared co-authors 5
Robert W Sobol
University of South Alabama
Career Start Year 1987
Number of shared co-authors 1
Eivind Hovig
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 1
Brent W Zanke
University of Toronto
Career Start Year 1987
Number of shared co-authors 3
William C Reinhold
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 1
Ching C Lau
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 10
David J Adams
Wellcome Sanger Institute
Career Start Year 1980
Number of shared co-authors 3
Douglas D Ross
Greenebaum Comprehensive Cancer Center, University of Maryland
Career Start Year 1979
Number of shared co-authors 1
Robert H Shoemaker
National Cancer Institute
Career Start Year 1978
Number of shared co-authors 0
Stephen H Friend
University of Oxford
Career Start Year 1978
Number of shared co-authors 1
Anne Monks
Institute of Biomedical Engineering (IBME), University of Oxford
Career Start Year 1976
Number of shared co-authors 1
David W Hedley
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1975
Number of shared co-authors 1
James Koropatnick
Western University, Lawson Health Research Institute
Career Start Year 1975
Number of shared co-authors 0
Paul Workman
The Institute of Cancer Research
Career Start Year 1974
Number of shared co-authors 3
Stephen B Howell
Moores Cancer Center and Department of Medicine, University of California
Career Start Year 1974
Number of shared co-authors 0
James H Doroshow
National Cancer Institute, National Institutes of Health
Career Start Year 1974
Number of shared co-authors 9
Michelle Haber
School of Clinical Medicine
Career Start Year 1973
Number of shared co-authors 12
J??rgen Thomale
University Hospital Essen
Career Start Year 1972
Number of shared co-authors 1
Garth Powis
PHusis Therapeutics Inc.
Career Start Year 1970
Number of shared co-authors 1
John N Weinstein
The University of Texas MD Anderson Cancer Center
Career Start Year 1968
Number of shared co-authors 2
J. Carl Barrett
Oncology R&D
Career Start Year 1966
Number of shared co-authors 4
Robert B Diasio
Mayo Clinic
Career Start Year 1965
Number of shared co-authors 16

Collaborators

Nancy J Cox
Vanderbilt University Medical Center
Co-authored papers 45
Eric R Gamazon
Vanderbilt University Medical Center
Co-authored papers 34
Heather E Wheeler
Co-authored papers 31
Mark J Ratain
University of Chicago
Co-authored papers 24
Henry S Friedman
Co-authored papers 20
Hae Kyung Im
Co-authored papers 18
Darell D Bigner
Co-authored papers 15
Stephen T Keir
Co-authored papers 7
Mary V Relling
Departments of Pharmaceutical Sciences.
Co-authored papers 7
Michiaki Kubo
Co-authored papers 6
Howard L McLeod
Center for Precision Medicine and Functional Genomics, Utah Tech University
Co-authored papers 6
Roger E McLendon
Co-authored papers 6
Edwin H Cook
Co-authored papers 6
Lucy A Godley
The University of Chicago
Co-authored papers 6
Kristine R Crews
St. Jude Children's Research Hospital
Co-authored papers 5
Judith A Badner
Rush University Medical College
Co-authored papers 5
Deanna L Kroetz
University of California San Francisco
Co-authored papers 5
Jeremy N Rich
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Co-authored papers 5
Michael T Eadon
Co-authored papers 4
Cheng Cheng
St. Jude Children's Research Hospital
Co-authored papers 4
Ching-Hon Pui
St. Jude Children's Research Hospital
Co-authored papers 4
Anuar Konkashbaev
Co-authored papers 4
Stanley Pounds
St. Jude Children's Research Hospital.
Co-authored papers 4
Kevin P White
Co-authored papers 4
Leona D Samson
Massachusetts Institute of Technology
Co-authored papers 3
Peter J Houghton
The University of Texas Health Science Center at San Antonio
Co-authored papers 3
Teri E Klein
Stanford University
Co-authored papers 3
Susan L Cohn
Co-authored papers 3
James M Provenzale
Duke University Medical Center
Co-authored papers 3
Yves A Lussier
Center for Biomedical Informatics and Biostatistics, University of Arizona
Co-authored papers 3
Release 1.2